课题基金 / 基金详情

Duke Infectious Disease Response Training Consortium (DIDRT)

Duke Infectious Disease Response Training Consortium (DIDRT)
杜克大学传染病应对培训联盟 (DIDRT)
批准号:
9493482
负责人:
Gregory D Sempowski
金额:
$38.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-01 至 2019-05-31

项目摘要

项目成果

Gregory D Sempowski的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Three epidemics (SARS in 2003, pandemic influenza in 2009, and Ebola in 2014) have tested our national preparedness for infectious disease emergencies, revealing both strengths and weaknesses. Identified weaknesses have highlighted the need for a national network of training consortium to ensure up-to-date, high quality, effective and efficient delivery of biosafety and infectious disease worker training. In response to the anthrax attacks of 2001, the NIAID/NIH funded construction of a network of Regional Biocontainment Laboratories (RBLs) with a mandate to support local and national responses to infectious disease emergencies. RBLs were strategically constructed at major academic medical centers and provide a nexus of training and outreach to healthcare and non-healthcare workers in their respective geographical catchment areas. The RBL at Duke University Medical Center was the first of the 12 RBLs to be fully commissioned in 2007 and has a comprehensive biosafety and infectious disease preparedness training program with an emphasis on CDC/NIAID Category A, B and C priority pathogens for multiple worker populations. In 2014 the RBL at Duke training team was activated to develop an Ebola treatment unit at Duke University Hospital, develop a care network for an Ebola suspect patient, and train custodial and healthcare workers. Consistent with the overall goal of the NIEHS worker training program we propose to use a subset of the NIAID-RBLs (Duke, Colorado State, U. Chicago, George. Mason U., and U. Louisville) to establish a multistate partnership to provide training in occupational settings that carry the potential for increased exposure to contaminated materials or infected individuals. We call this program Duke Infectious Disease Response Training (DIDRT). We will achieve this goal by accomplishing the following three Specific Aims: 1) Develop a multistate consortium of biosafety professionals within the NIAID RBL network to provide comprehensive infectious disease response training; 2) Train worker populations (first responders, custodial service, travel/Air transport, and healthcare/clinical lab) with important roles in infectious disease response; and 3) Evaluate the efficacy of preparedness training, incorporating the results in a continuous quality improvement cycle. The DIDRT consortium is uniquely qualified to achieve these three Aims. Our five-state consortium includes key leaders in the American Biological Safety Association (ABSA), including two former ABSA presidents (Hunt and Ellis), three former/current ABSA board members (Hunt, Alderman and Ellis), five Certified Biological Safety Professionals (Hunt, Frothingham Alderman, Ellis and Blair), and five Registered Biosafety Professionals (Burch, Blair, Zobel, Bivona, Quenee). Our RBL consortium members provide regular biosafety training (over 110,000 in the past five years) in formats ranging from short online modules to five-day courses. The collective knowledge of our team and th e strategic geographic locations of the DIDRT consortium members will enable the development of a truly nationwide program capable of meeting the needs of the NIEHS WTP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core 2: Biocontainment and Immune Monitoring Core
  • 批准号:
    10327521
  • 项目类别:
  • 资助金额:
    $246.81万
  • 财政年份:
    2021
  • 负责人:
    Gregory D Sempowski
  • 依托单位:
Core 2: Biocontainment and Immune Monitoring Core
  • 批准号:
    10842500
  • 项目类别:
  • 资助金额:
    $144.71万
  • 财政年份:
    2021
  • 负责人:
    Gregory D Sempowski
  • 依托单位:
Core C: Thymic and peripheral Aspects of T cell Aging and Rejuvenation
  • 批准号:
    10226918
  • 项目类别:
  • 资助金额:
    $11.15万
  • 财政年份:
    2017
  • 负责人:
    Gregory D Sempowski
  • 依托单位:
BSL3 Flow Biomarker and Imaging
海外基金